As Europe’s adoption of the IDMP data model advances, EMA’s centralised Product Management Services (PMS) platform is coming ...

Over the past two decades, clinical trials have undergone significant transformation. Historically, trials followed a ...

The recent landmark ruling by the UK’s Supreme Court – that the term “sex” in the Equality Act 2010 refers to biological sex, ...

In a sector defined by innovation, evidence and outcomes, the true catalyst for transformation is often overlooked: ...

The recent bankruptcy filing of WeightWatchers marks more than just the downfall of a household name: rather, a shift in how ...

Emerging evidence reveals a clinically significant rebound effect following the discontinuation of glucagon-like peptide-1 ...

What else is there to share? As it happens, quite a lot. Last time I spoke about the diagnosis of Young Onset Parkinson’s disease (YOPD), how this presented several day-to-day challenges from securing ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...

The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research ...

Worldwide Clinical Trials has appointed Stephen Rayda as its first Chief Digital and Information Officer, expanding the ...